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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of the integrated community case management (iCCM) strategy for children younger than five years of age in low-
and middle-income countries.
B A C K G R O U N D
Description of the condition
In 2015 an estimated 5.9million children died before reaching the
age of five, mostly in low- and middle-income countries (LMICs)
and particularly the regions of sub-Saharan Africa (SSA) (50%
of deaths) and South Asia (31% of deaths) (You 2015). Cause
of death estimates suggest that most under-five deaths are due
to preventable or treatable conditions (Liu 2015). As of 2013
(the latest year for which data were available), 52% of under-
five mortality globally was caused by infectious diseases including
pneumonia (16%), diarrhoea (10%), and malaria (14%) (Liu
2015). In SSA 40% of under-five deaths were due to pneumonia,
malaria, and diarrhoea and 34% were due to neonatal causes - a
subset of whichwere also related to severe infections (Liu 2015). In
South Asia, 54% of under-five deaths were due to neonatal causes,
a subset of which were related to severe infections. Pneumonia and
diarrhoea were also major causes, contributing 14% and 10% of
the total respectively (Liu 2015).
Efficacious interventions for addressing the major causes of pre-
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ventable under-five mortality exist (Darmstadt 2005; Jones 2003).
In the mid-1990s the World Health Organization (WHO), the
United Nations Children’s Fund (UNICEF), and technical part-
ners developed a strategy called the Integrated Management of
Childhood Illness (IMCI) to reduce child mortality, illness and
disability, and to promote improved growth and development
among children younger than five years of age (Tulloch 1999;
WHO1997). IMCI includes threemain components (Gera 2016;
Tulloch 1999): 1) improvements in case-management skills of
health staff through the provision of locally adapted guidelines
on integrated management of childhood illness and activities to
promote their use; 2) improvements in the health system required
for effective management of childhood illnesses; and 3) improve-
ments in family and community practices.
IMCIwas designed todeliver treatment interventions of known ef-
ficacy for the main causes of under-five mortality through an inte-
grated case management approach, recognizing that children pre-
senting at health facilities often have multiple, overlapping signs
and symptoms of these conditions (Fenn 2005; O’Dempsey 1993;
Tulloch 1999; WHO 1997). A Cochrane Review of IMCI con-
cluded with low certainty that IMCI may reduce child mortality,
may reduce infant mortality (where interventions for the neonatal
period are included), and may have mixed effects on care-seeking
behaviour, morbidity and quality of care (Gera 2016).
In an earlier multi-country evaluation of IMCI, Bryce and col-
leagues found that “improving the quality of care in first-line gov-
ernment health facilities was not sufficient” to improve low uti-
lization and population coverage; the components on health sys-
tems and family and community practices were slow to be imple-
mented (if at all); and they concluded that “Delivery systems that
rely solely on government health facilities must be expanded to
include the full range of potential channels in a setting and strong
community-based approaches...we must move beyond health fa-
cilities, and develop new and more effective ways of reaching chil-
dren with proven interventions to preventmortality. In most high-
mortality settings, this means providing case management at com-
munity level, as well as focusing on prevention and reducing rates
of undernutrition” (Bryce 2005).
Other researchers have also found accessibility of treatment ser-
vices at government health facilities to be inadequate, particularly
in SSA (Blanford 2012; Huerta Munoz 2012; Noor 2003; Noor
2006; Tsoka 2004).
Description of the intervention
In the 2000s theWHO and UNICEF, in collaboration with other
development partners, developed an approach - now known as
integrated community case management (iCCM) - to bring treat-
ment services ’closer to home’ and advocated for LMICs to adopt
it (Bennett 2015; Diaz 2014; WHO/UNICEF 2012). The adop-
tion of iCCM has been rapid, particularly in sub-Saharan Africa
where most countries have some form of written policy to enable
implementation of iCCM (Rasanathan 2014).
Definition
iCCM is an extension of IMCI - providing treatment services
outside of the healthcare facility at community level (Bennett
2015; Gera 2016); and c-IMCI - the original community-based
component of IMCI which focused on promoting key family
and community practices for improving child health (WHO
1997). iCCM is an approach to providing integrated case man-
agement services for two or more illnesses - including diarrhoea,
pneumonia, or malaria (the latter in malaria-affected countries)
- among children younger than five years of age at community
level (i.e. outside of healthcare facilities) by lay health workers
where there is limited access to health facility-based case manage-
ment services (WHO/UNICEF2012). Casemanagement services
as defined here include assessment, treatment, and referral ser-
vices (WHO/UNICEF 2012), following locally adapted WHO/
UNICEF guidelines (WHO 2011). In some contexts iCCM may
also include case management services for acute malnutrition and
newborn illness (Rasanathan 2014; WHO 2007). iCCM is con-
sidered an equity-focused approach in that it is primarily imple-
mented in rural and hard-to-reach areas with limited access to fa-
cility-based case management services (WHO/UNICEF 2012).
Components of the intervention
There are three main components of iCCM (Diaz 2014;
McGorman 2012; WHO/UNICEF 2012; Young 2012). Table 1
classifies the three main components of iCCM according to the
Effective Practice and Organization of Care (EPOC) taxonomy
of health systems interventions (EPOC 2015), providing a frame-
work and common language for understanding and describing
iCCM and its component interventions. The three main compo-
nents of iCCM are summarized below:
1. Training and deployment component: interventions with the
main purpose of increasing access to integrated case management
services for children younger than five years of age by increasing
the number of lay health workers trained on the generic or adapted
WHO/UNICEF guidelines for integrated case management ser-
vices and deployed where facility-based case management services
are limited.
2. Systems component: interventions with the main purpose of
improving implementation of iCCM by strengthening health sys-
tems’ organization and management, including supplies, specifi-
cally related to iCCM.
3. Communication and community mobilization component: in-
terventionswith themain purpose of promoting good practices for
health and nutrition and generating demand for case management
services for ill children through communication and mobilization
of communities and caregivers.
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iCCM providers
iCCM providers may include any lay health workers (paid or vol-
untary) who:
• provide iCCM (integrated case management services for
two or more illnesses among children younger than five years of
age);
• are trained on iCCM, but have received no formal
professional or paraprofessional certificate or tertiary education
degree (adapted from Lewin 2010).
This definition includes iCCM providers who receive a certificate
on completion of their iCCM training but excludes healthcare
providers who receive pre-licensure or post-licensure training cer-
tified by a professional body, such as a nursing or midwifery coun-
cil.
Package of services
iCCM providers deliver integrated case management services for
two or more illnesses among children younger than five years of
age (WHO/UNICEF 2012; Young 2012), including:
• assessment and classification of the child’s condition(s)
using a simplified IMCI-adapted algorithm;
• referral of cases with general danger signs and other
complicated cases;
• provision of treatment for the following conditions:
◦ non-severe pneumonia with oral antibiotics;
◦ non-severe diarrhoea with oral rehydration salts and
zinc;
◦ non-severe malaria with artemisinin-based
combination therapy (in malaria-affected countries).
iCCM may also include assessment, classification and treatment
of neonatal sepsis with oral antibiotics and referral as necessary;
and assessment, classification and treatment of uncomplicated se-
vere acute malnutrition (SAM)with ready-to-use therapeutic food
and oral antibiotics, with referral as necessary (Rasanathan 2014;
WHO 2007).
How the intervention might work
Interventions in the training and deployment component target
lay health workers to improve access to integrated case manage-
ment services for children younger than five years of age at com-
munity level where facility-based case management services are
limited. The logic of these interventions assumes that increasing
the number of lay health workers trained to deliver integrated case
management services based on locally adapted WHO/UNICEF
guidelines (WHO 2011) for children younger than five years of
age (who may present with multiple, overlapping symptoms), and
deploying them to areas where facility-based case management
services are limited, will improve the availability and geographic
accessibility of integrated case management services by bringing
these services closer to caregivers (Diaz 2014; WHO/UNICEF
2012; Young 2012).
Interventions in the systems component aim to strengthen health
systems components such as supply chain management, supervi-
sion, referral pathways, and health management information sys-
tems. The logic of these interventions assumes that effective iCCM
implementation is dependent on a continuous supply of drugs
and diagnostic tools, regular supervision, effective referral mecha-
nisms, and a strong health management information system.
Interventions in the communication and community mobiliza-
tion component target communities and caregivers with the main
purpose of promoting good practices for health and nutrition and
generating demand for case management services for ill children
through communication and mobilization of communities and
caregivers. The logic of these interventions assumes that effective
iCCM implementation is dependent on effective communication
and mobilization strategies, plans, materials, and messages around
good health and nutrition practices as well as for increasing de-
mand for case management services.
Why it is important to do this review
WHO and UNICEF have endorsed iCCM (WHO/UNICEF
2012); and the uptake of iCCM by national governments has been
rapid (Rasanathan 2014; UNICEF 2005). Evidence-based policy
making is critical to health outcomes (Bosch-Capblanch 2012;
Langlois 2015; Lavis 2009; Oliver 2014). To date no systematic
review of iCCM - that is, as an integrated approach for the man-
agement of diarrhoea, pneumonia, malaria (in malaria-affected ar-
eas), acute malnutrition, or newborn sepsis (or combinations of
these conditions) at the community level by lay health workers -
has been undertaken. This presents an important information gap
relevant to evidence-based decision making of the general public,
practitioners, policy makers, and researchers in low- and middle-
income countries.
Systematic reviews have been undertaken and published on sin-
gle-disease community case management (CCM) - that is CCM
for diarrhoea (Das 2013), CCM for malaria (Okwundu 2013;
Ruizendaal 2014; Sazawal 2003) and CCM for pneumonia (Das
2013; Druetz 2013; Ruizendaal 2014; Sazawal 2003) - among
children younger than five years of age in LMICs. The reviews
that used the GRADE approach for assessing certainty of the ev-
idence reported moderate-certainty evidence for the effectiveness
of CCM on care-seeking behaviour (Das 2013), mostly moderate-
certainty evidence for the effectiveness of CCM on appropriate
treatment (Das 2013; Okwundu 2013) and timeliness of treat-
ment (Okwundu 2013), and mostly moderate-certainty evidence
for effectiveness of CCM on mortality among children younger
than five years of age (Das 2013, Okwundu 2013). Two reviews
(Das 2013 and Druetz 2013) included studies on iCCM; however
only Das 2013 used GRADE and both were primarily focused on
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the effects of CCM - not iCCM - and therefore did not address
the objectives of this review.
A review of community-based management of pneumonia by
Theodoratou 2010 included studies on CCM by lay health work-
ers but did not report these results separately from the results of
studies that included other types of healthcare workers such as
nurses.
A systematic review assessed the evidence for the effect of integrat-
ing CCM for malaria with other interventions, including CCM
for pneumonia, on outcomes for CCM for malaria - in particular
quality of care and facilitators and barriers to high-quality CCM
for malaria (Smith Paintain 2014). They found that integrating
additional interventions with case management services at com-
munity level for malaria did not reduce the quality of the malaria
services in contexts where training and supervision were main-
tained but quality of pneumonia case management was lower and
variable (Smith Paintain 2014). This review did not use GRADE
and was focused on the effects of iCCM on malaria outcomes, not
outcomes across diseases as in this review.
A “scoping review” of the training, supervision and quality of care
of iCCM that did not use GRADE reported evidence of positive
effects on quality of care in large iCCM programmes where multi-
faceted interventions including training, supervision, and supply
chain management were implemented (Bosch-Capblanch 2014).
Amouzou and colleagues undertook a non-systematic review of
the effect of iCCM on child mortality in sub-Saharan Africa and
found that large heterogeneity of programme implementation and
evaluation design precluded meta-analysis but revealed in six of
eight studies a greater decline in mortality among children aged 2
to 59 months in intervention areas compared to comparison areas
(Amouzou 2014).
Other systematic and non-systematic reviews have covered the
effectiveness of lay health workers in terms of providing a range of
maternal, newborn, and child health interventions (Christopher
2011; Hopkins 2007; Lewin 2010; Sanders 2007; Zaidi 2009).
The current reviewwill build onprevious reviews -which primarily
focused on CCM or effects of iCCM on outcomes for a single
disease - by focusing on the effects of iCCM as an integrated
approach on outcomes across diseases using the rigorous Cochrane
methodology, including the GRADE approach for assessing the
certainty of the evidence.
O B J E C T I V E S
To assess the effects of the integrated community casemanagement
(iCCM) strategy for children younger than five years of age in low-
and middle-income countries.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will consider types of studies for inclusion based on EPOC
guidance (EPOC 2017a).
• Randomised trials, including cluster-randomised trials,
with at least two intervention (iCCM) sites and at least two
control sites (no iCCM).
• Non-randomised trials with at least two intervention
(iCCM) sites and at least two control (no iCCM) sites and
adjustment for baseline characteristics and confounders.
• Controlled before after studies (CBAs) with at least two
intervention (iCCM) sites and at least two control (no iCCM)
sites in which allocation to different comparison groups was not
made by study investigators, and outcomes were measured in
both intervention and control groups at baseline and after the
iCCM programme had been introduced.
• Interrupted time series studies with a clearly defined point
in time when the intervention (iCCM) occurred and at least
three data points before and three after the introduction of
iCCM. We will use the EPOC standard criteria for assessing the
methodological quality of ITS designs for inclusion.
• Repeated measures studies, specifically interrupted time
series studies where measurements are made in the same
individuals at each time point.
As a strategy, iCCM was intended to target areas within LMICs
with poor geographic accessibility to facility-based case manage-
ment services, and this review intends to provide evidence relevant
to policy in these settings. For this reason, included studies will be
restricted to LMICs as categorized by the World Bank using gross
national income per capita in US dollars and the Atlas conversion
factor (World Bank 2012). We will not restrict the inclusion of
studies by language, publication status or date of publication. We
will consider for inclusion full-text published studies, conference
abstracts, and unpublished full-text studies, as well as unpublished
data.
Types of participants
Types of recipients
Types of recipients will include children younger than five years
of age and their caregivers in LMICs.
Types of healthcare providers
Types of healthcare providers will include any lay health workers
(paid or voluntary) who
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• provide iCCM (integrated case management services for
two or more illnesses among children younger than five years of
age);
• are trained on iCCM, but have received no formal
professional or paraprofessional certificate or tertiary education
degree (adapted from Lewin 2010).
Types of interventions
We will consider for inclusion studies on the implementation of
generic WHO/UNICEF iCCM intervention (or local adaptation
thereof ) for at least two of the following iCCM diseases: diar-
rhoea, malaria (in endemic areas), pneumonia, severe acute mal-
nutrition and newborn sepsis. We will also consider for inclusion
studies with implementation of unbranded iCCM (i.e. where the
intervention is not called by the name “iCCM” but where generic
WHO/UNICEF iCCM for at least two iCCM diseases has been
implemented).We recognize that iCCM in some contexts may in-
clude other childhood illnesses. We will consider studies of iCCM
that include other childhood illnesses (e.g. antiretroviral therapy
adherence for HIV, paediatric TB services) as long as they include
at least two iCCM diseases.
To be considered for inclusion, a study must at minimum in-
clude training and deployment of lay health workers for iCCM as
one component plus systems interventions to supply the necessary
commodities and equipment with or without other systems in-
terventions or interventions for community mobilisation and en-
gagement. We recognize that iCCM may involve multiple health
systems interventions and interventions for communication and
community mobilization (Table 1) not all of which may be imple-
mented in all contexts, in the same way or with the same strength.
Since we expect there to be large variation between studies in the
number and type of diseases being managed we anticipate not
presenting one overall summary estimate but rather stratifying on
two levels.
1) Two ormore disease iCCMversus one disease CCMor standard
facility-based care (case management for children younger than
five years of age provided by nurses or doctors at first line facilities
in LMICs).
2) three or more disease iCCM versus one disease CCM or stan-
dard facility-based care.
This will enable a comparison of two different levels of integrated
case management services versus single disease case management
services and standard facility care which is of policy relevance
for countries considering establishing a community-based delivery
platform for case management of childhood illnesses.
Comparison
We will include studies comparing programmes that implement
the integrated community casemanagement (iCCM) strategywith
single disease community case management (CCM) and standard
facility care. We also suspect that effects will vary depending on
a number of programme and contextual factors. These are sum-
marized in Subgroup analysis and investigation of heterogeneity
(below).
Types of outcome measures
Reporting of the outcomes listed here will not be an inclusion
criterion for the review and we will include studies regardless of
the assessed outcomes.
Primary outcomes
1. Coverage of appropriate treatment: the proportion of
children younger than five years of age with one or more
childhood illnesses (diarrhoea, malaria, pneumonia, severe acute
malnutrition, or newborn sepsis) that receive appropriate
treatment from an ’appropriate provider’ of treatment services
(trained, certified or otherwise qualified public or private
provider, including iCCM providers). This could include oral
rehydration therapy and zinc for diarrhoea, antimalarial drug
prescription for fever, Ready-to-Use Therapeutic Foods (RUTF)
for severe acute malnutrition, and antibiotics for newborn sepsis.
Pneumonia treatment is not included due to the lack of a valid
household survey indicator of pneumonia treatment (Bryce
2013). Pneumonia is included under the secondary outcome
coverage of care seeking.
2. Quality of care assessed by adherence to standard/adapted
WHO/UNICEF iCCM practice guidelines. This could include
correct assessment (iCCM provider’s assessment matched a gold
standard assessment); correct classification (iCCM provider’s
classification matched a gold standard classification); and correct
treatment (iCCM provider’s treatment matched a gold standard
treatment). We will not exclude studies using other standards or
indicators.
3. Case load or severity of illness at health facilities. This could
include the proportion of facility case load made up by severe
diarrhoea, severe malaria (in endemic settings), severe
pneumonia, and cases with general danger signs or other
complications.
4. Measures of mortality (neonatal, infant, under-five
mortality and any mortality (neonatal + under-five mortality))
5. Adverse events
Secondary outcomes
1. Coverage of care-seeking to an ’appropriate provider’ of
treatment services. This could include care-seeking to a trained,
certified or otherwise qualified public or private provider
(including iCCM providers) for diarrhoea, fever, suspected
pneumonia, malnutrition or newborn sepsis.
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Search methods for identification of studies
Electronic searches
Wewill search the following electronic databases for primary stud-
ies without any language or time limits:
• The Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library,
www.cochranelibrary.com, (including the Cochrane Effective
Practice and Organisation of Care (EPOC) Group Specialised
Register).
• MEDLINE, OvidSP.
• Embase, OvidSP.
To test whether or not to search Embase, we will search Embase
and MEDLINE for the phrase ’integrated community case man-
agement’ in title, abstract and keywords. We will screen all records
that are unique to Embase, and will only do a systematic search of
Embase if any of these records are eligible for inclusion.
See Appendix 1 for the MEDLINE strategy that has been peer
reviewed using the Peer Review of Electronic Search Strategies
(PRESS) checklist (Sampson 2008).
Searching other resources
Grey Literature
• Open Grey (www.opengrey.eu).
• Grey Literature Report (www.greylit.org).
• Any other relevant grey literature resources.
Trial Registries
• International Clinical Trials Registry Platform (ICTRP),
Word Health Organization (WHO) (www.who.int/ictrp).
• ClinicalTrials.gov, US National Institutes of Health (NIH)
(ClinicalTrials.gov).
We will also
• search for relevant studies in the reference list of all
included studies;
• conduct cited reference searches for all included studies
using Web of Science, Thomson Reuters.
Data collection and analysis
Selection of studies
We will download all titles and abstracts retrieved by electronic
searching to a reference management database and remove dupli-
cates. At least two review authors (from among NO; DB; WO;
KL; EJ; MK; TD; KD) will independently screen titles and ab-
stracts for inclusion. We will code all the potentially eligible stud-
ies as ’retrieve’ (eligible or potentially eligible/unclear) or ’do not
retrieve’. We will retrieve the full text study reports/publication
and at least two review authors (from among NO; DB; WO; KL;
EJ; MK; TD; KD) will independently screen the full text, identify
studies for inclusion and identify and record reasons for exclusion
of the ineligible studies. We will resolve any disagreement through
discussion or, if required, we will consult a third reviewer (one
of the eight review authors who had not originally screened the
particular title, abstract or full text). We will list in ’Characteristics
of excluded studies’, with reasons for their exclusion, studies that
initially appear to meet the inclusion criteria but which we later
rejected. We will collate multiple reports of the same study so that
each study rather than each report is the unit of interest in the
review. We will also provide any information we can obtain about
ongoing studies. We will record the selection process in sufficient
detail to complete a PRISMA flow diagram (Liberati 2009); and
a ’Characteristics of excluded studies’ table.
Data extraction and management
We will use a standard data collection form, adapted from the
EPOC Good Practice Data Collection Form (EPOC 2017b) and
piloted on at least one study in the review, to gather study charac-
teristics and outcome data. Two reviewers per study from among
the eight reviewers (NO; DB; WO; KL; EJ; MK; TD; KD) will
independently extract the following study characteristics from in-
cluded studies.
1. Methods: study design, number of study centres and
location, study setting, withdrawals, date of study, follow-up.
2. Participants: number, mean age of children, age range of
children, sex of the child, socio-economic status (country
baseline income level as defined by the HDI; household wealth
defined as household assets or income), type of condition,
diagnostic criteria, inclusion criteria, exclusion criteria, other
relevant characteristics.
3. Interventions: intervention components, comparison,
fidelity assessment; Where multiple trial arms are reported in a
single trial, we will include only the relevant arms.
4. Outcomes: primary and secondary outcomes specified and
collected, time points reported. We will extract information
separately for two of the PROGRESS groups specified for
subanalysis (O’Neill 2014): socio-economic status (country
baseline income level as defined by the HDI and household
wealth defined as household assets or income); and sex of the
child.
5. Notes: funding for trial, all stated conflicts of interest of
trial authors, ethical approval.
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Two reviewers - from among the eight reviewers - will indepen-
dently extract outcome data from included studies. We will note
in the ’Characteristics of included studies’ table if outcome data
were reported in an unusable way. We will resolve disagreements
by consensus or by involving a third reviewer (one of the eight re-
view authors who had not originally extracted from the full text).
NO will not be involved in data extraction for studies supported
by UNICEF or the Global Fund to Fight AIDS, Tuberculosis, and
Malaria (see ’Declarations of interest’ section)
Assessment of risk of bias in included studies
Two review authors (NO and TD) will independently assess risk
of bias for each study using guidance from theCochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011) and EPOC
(EPOC 2017c). NOwill not be involved in risk of bias evaluation
for studies supported by UNICEF or the Global Fund to Fight
AIDS, Tuberculosis, and Malaria (see ’Declarations of interest’
section). NO and TD will resolve any disagreement by discussion
or by involving a third assessor (KD).Wewill assess and present the
risk of bias for studies with a separate control group (randomized
trials, non-randomized trials, and controlled before after studies)
according to the nine standard criteria suggested by EPOC (EPOC
2017c).
1. Was the allocation sequence adequately generated?
2. Was the allocation adequately concealed?
3. Were baseline outcome measurements similar?
4. Were baseline characteristics similar?
5. Were incomplete outcome data adequately addressed?
6. Was knowledge of the allocated interventions adequately
prevented during the study?
7. Was the study adequately protected against contamination?
8. Was the study free from selective outcome reporting?
9. Was the study free from other risks of bias?
We will assess and present the risk of bias for interrupted time
series studies according to the seven standard criteria suggested by
EPOC (EPOC 2017c).
1. Was the intervention independent of other changes?
2. Was the shape of the intervention effect pre-specified?
3. Was the intervention unlikely to affect data collection?
4. Was knowledge of the allocated interventions adequately
prevented during the study?
5. Were incomplete outcome data adequately addressed?
6. Was the study free from selective outcome reporting?
7. Was the study free from other risks of bias?
Following EPOC guidance we will provide a summary assessment
of the risk of bias for each important outcome (across domains),
including all of the entries relevant to that outcome, within and
across studies (EPOC 2017d). For each domain we will provide
a judgement and a quotation in support of the judgement. The
judgement for each outcome will assess the risk of bias as ’low risk’
(low risk of bias for all key domains), as ’high risk’ (high risk of
bias for one or more key domains), or as ’unclear risk’ (unclear
risk of bias for one or more key domains) (EPOC 2017d).We will
interpret ’low risk’ of bias to mean plausible bias that is unlikely
to seriously alter the results; ’high risk of bias’ to mean plausible
bias that seriously weakens confidence in the results; and ’unclear
risk’ of bias to mean plausible bias that raises some doubt about
the results (Table 2; EPOC 2017d). We will consider blinding
separately for different key outcomes where necessary (e.g. for un-
blinded outcome assessment, risk of bias for mortality may be very
different than for reported care-seeking). Where information on
risk of bias relates to unpublished data or correspondence with a
trialist, we will note this in the ’Risk of bias’ table. We will create
plots of ’Risk of bias’ assessments in Review Manager 5 (RevMan
5) (Review Manager 2014). Disagreements about risk of bias will
be resolved by discussion between the authors assessing risk of bias
or by group discussion, if necessary. We will not provide a sum-
mary assessment of the risk of bias for a study across outcomes
because we cannot assume the risk of bias is the same for all out-
comes in a study and generally a summary assessment of the risk
of bias across outcomes is of little interest. We will not provide a
summary assessment of the risk of bias for the review as a whole
(across studies and outcomes) because this would require value
judgements about which outcomes are critical to a decision: these
judgements may vary across settings, and this review is intended
to inform decisions across a variety of settings (Higgins 2011).
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
Assessment of bias in conducting the systematic
review
We will conduct the review according to this published protocol
and report any deviations from it in the ’Differences between pro-
tocol and review’ section of the systematic review.
Measures of treatment effect
Dichotomous outcomes
For RCTs, NRCTs and CBA studies, we will record outcomes in
each comparison group. Where possible we will record or calcu-
late risk ratios (RRs) and odds ratios (ORs) for dichotomous out-
comes. If CBA studies do not provide an appropriate analysis or
reporting of results but present the data for each district/region in
the intervention and control groups respectively, for dichotomous
outcomes we will re-analyse the data using a generalised linear
model to calculate an adjusted RR.
If adjusted analyses are reported for dichotomous outcomes (ad-
justing for potential confounders in RCTs, NRCTs and CBAs),
we will use estimates of effect from the primary analysis reported
by the investigators and convert these to RRs, if possible. In the
case where the adjusted analyses for dichotomous outcomes are
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reported using ORs and not RRs then we will use RevMan 5 to
convert ORs to RRs before we include the result in a meta-analysis
(Review Manager 2014).
Continuous outcomes
For continuous outcomes, we will express the effect size as mean
differences (MDs) with standard deviations (SDs) if outcomes are
measured in the same way between studies. If some included stud-
ies report endpoint data and others report change from baseline
data (with errors), wewill combine these in themeta-analysis if the
outcomes are reported using the same scale (Higgins 2011). We
will use standardised mean differences (SMDs) with 95% confi-
dence intervals (CIs) to combine data from trials that measure the
same outcome but use different scales.We will standardise the data
to their effect size by dividing the estimated MDs by their SDs.
For CBA studies, we will use difference in differences between pre-
and post-observation in intervention and control group. For time-
to-event data we will report hazard ratios or similar measures such
as risk ratios or survival rates.
Interrupted time series (ITS) studies
For ITS studies that meet the criteria for inclusion according to
EPOC2017e we will record changes in level and in slope. If papers
with ITSdesigndonot provide an appropriate analysis or reporting
of results but present the data points in a graph or in a table that we
can scan, we will re-analyse the data using the methods described
in Ramsay 2003.
Studies reporting multiple measures of the same outcome
When a single study uses two separate methods to measure the
same outcome (e.g. two measures of quality of care) or measures
two different outcomes that we could consider part of the same
outcome category (e.g. two different measures of access to treat-
ment services), we will adopt the approach to measures of treat-
ment effect outlined inBrennan 2009, Flodgren 2011 andGiguère
2012. We will select the primary outcome identified by the study
authors that correlates to our stated outcomes of interest. If the
study authors do not specify any primary outcomes, we will select
the one specified in the sample size calculation. If no sample size
calculations are reported, we will rank the reported effect estimates
and select the outcome with the median effect estimate. When
there is an even number of outcomes, we will include the outcome
whose effect estimate is ranked n/2, where n is the number of out-
comes.
Unit of analysis issues
For cluster randomised studies which do not adequately account
for clustering in their analysis, we will adjust the analysis for clus-
tering if the following information can be extracted.
• The number of clusters (or groups) randomised or allocated
to each intervention group, or the average (mean) size of each
cluster.
• The outcome data ignoring the cluster design for the total
number of individuals included in the study (for example,
number or proportion of individuals with events, or means and
standard deviations).
• An estimate of the intracluster (or intraclass) correlation
coefficient (ICC). Where no information on the ICC is reported,
we will extrapolate the ICC from other included cluster
randomised studies, if available. If this is not possible, we will
not combine the findings of these studies in a meta-analysis, but
will present the results in an additional table.
We will use inflated variances to adjust appropriately for clustering
(Higgins 2011). For cluster RCTs where study authors do not take
clustering into account in the original analysis andwhere reanalysis
is not possible, we will only report the estimate of effect (and not
the P value or CIs - the P value may be too small and the CIs too
narrow).
For area level analysis (e.g. districts as the unit of analysis) we will
not make inferences about the individuals based on the area to
which they belong, to avoid ecological fallacy.
Dealing with missing data
Wewill contact trial investigators and authors in order to verify key
study characteristics and obtain missing outcome data where pos-
sible (e.g. when a study is identified as abstract only). We will in-
vestigate causes of missing data and attrition rates and critically ap-
praise imputation methods used. If a study does not report means
and SDs for continuous outcomes and study authors have failed
to provide the needed information, then we will use the medians,
ranges and sample size to estimate the same. In some cases, the
pooled baseline SD will be used for follow-up data measurements.
We will assess the impact of imputations on meta-analysis as part
of sensitivity analyses.
If this is not possible we will report the data as missing and report
this in the Risk of bias tables and will not attempt to impute
values.
For all outcomes we will carry out analysis, as far as possible, on an
intention-to-treat (ITT) basis of available cases. We will attempt
to include all participants or clusters randomised to each group in
the analyses, and analyse data according to initial group allocation
irrespective of whether or not participants received, or complied
with, the planned intervention. When assessing adverse events,
adhering to the principle of ITT may be misleading and we will
therefore relate the results to the treatment received. This means
that for adverse effects we will base the analyses on the participants
who actually received the intervention and the number of adverse
events that are reported in the studies.
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For studies reporting per protocol analysis, we will ask the authors
to provide a full breakdown of information for all subjects - in-
cluding those that withdrew from, or did not comply with, the
protocol.
Assessment of heterogeneity
We will first make a qualitative assessment of the extent to which
the included studies are similar to each other. This will include an
assessment of the settings, the interventions, the participants and
outcomes. We will also examine the forest plots from the meta-
analyses, visually assessing the levels of heterogeneity (in terms
of the size or direction of treatment effect and by looking at the
overlap between CIs around the treatment effect estimate for each
included study). We will compute the Q statistic and use the Chi²
test (P < 0.10) to assess the presence or absence of heterogeneity of
effects beyond chance alone. When observed intervention effects
are more different from each other than one would expect due
to chance alone, we will assume that the studies have ’clinical’ or
statistical heterogeneity or both.
If we find a sufficient number of studies for a pre-specified out-
come we will conduct a meta-analysis. We will use the I² statistic
to quantify the level of statistical heterogeneity among the trials
in each analysis. If we identify substantial or considerable hetero-
geneity (approximately an I² statistic value of 50% to 100%) we
will not undertake pooled estimates; we will note this in the text,
and we will explore this heterogeneity through the prespecified
subgroup analyses. We will interpret with caution results from
meta-analyses with high levels of unexplained heterogeneity.
Assessment of reporting biases
We will attempt to be as comprehensive as possible in our search
strategy so as to find and include all relevant studies and to re-
duce any possible publication bias. This will include a search of
published studies, grey literature, registers of prospective trials and
discussions with colleagues (Higgins 2011).
We will attempt to contact study authors, asking them to provide
missing outcome data. Where this is not possible, and the missing
data are thought to introduce serious bias, the impact of including
such studies in the overall assessment of results will be explored by
a sensitivity analysis.
We will use funnel plots to make a visual assessment of whether
there is asymmetry, which may signal the presence of reporting
bias, even if it is not a definitive indicator of such bias. If we find
more than 10 studies that report similar outcomes, we will create
and examine a funnel plot to explore possible publication biases,
interpreting the results with caution (Sterne 2011).
For continuous outcomes with intervention effects measured as
mean differences, we will use the test proposed in Egger 1997 to
test for funnel plot asymmetry. For dichotomous outcomes with
intervention effects measured as RRs or ORs, and continuous
outcomeswith intervention effectsmeasured as SMDs, wewill not
consider funnel plot calculations because funnel plots using risk
differences are seldom of interest (Egger 1997). We will interpret
the results of tests for funnel plot asymmetry in the light of visual
inspection of the funnel plot, as the statistical results may not be
representative if there are small-study effects.
Data synthesis
Wewill undertake meta-analyses only where this is meaningful i.e.
if the treatments, participants and the underlying clinical question
are similar enough for pooling to make sense. A common way
that trialists indicate when they have skewed data is by reporting
medians and interquartile ranges. When we encounter this we
will note that the data is skewed and consider the implication
of this. Where multiple trial arms are reported in a single trial,
we will include only the relevant arms. If two comparisons (e.g.
intervention A versus usual care and intervention B versus usual
care) must be entered into the same meta-analysis, we will halve
the control group to avoid double counting.
If there is no evidence of heterogeneity we will carry out a meta-
analysis using a fixed-effect model to provide an overall estimate
of treatment effect when more than one study examines similar
interventions provided that studies use similarmethods; studies are
similar regarding setting; and studies measure the same outcome
in similar ways in comparable populations. Given the complexity
of the intervention and varying contexts of implementation, we
are likely to find evidence of heterogeneity. If this is the case wewill
use a random-effects meta-analysis. For continuous variables we
will use the inverse-variance method. For dichotomous variables
we will use the method proposed by Mantel 1959. If cluster RCTs
meet the inclusion criteria, we will use the generic inverse-variance
method. We will carry out all statistical analysis using Stata v14
(StataCorp 2015).
For ITS and repeated measures studies, the preferred analysis
method is either a regression analysis with time trends before
and after the intervention, adjusted for autocorrelation and any
periodic changes; or auto-regressive integrated moving average
(ARIMA) analysis. We will attempt to present the results for
outcomes as changes along two dimensions: change in level and
change in slope. Since the interpretation of change in slope can be
difficult, we will present the long-term effects similarly to the way
we plan to calculate and present the immediate effects. We will
use the generic inverse-variance method for combining the data
in a meta-analysis for each NRCT study design (ITS and CBA
studies) separately.
Wewill report the results of themeta-analysis as part of a structured
synthesis and will include forest plots where appropriate (EPOC
2017g). We will not combine results from RCTs and NRCTs to-
gether in meta-analysis, nor will we present pooled estimates for
NRCTs with different types of study designs. Evidence on differ-
ent interventions may be available from different types of studies
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(for example, it is likely that interventions implemented at the
national level will have been evaluated in NRCTs rather than ran-
domised trials). Where there is evidence on a particular outcome
from both RCTs and NRCTs, we will use the evidence from trials
that are at lower risk of bias to estimate treatment effect.
We will create a ’Summary of findings’ table using the following
outcomes.
1. Coverage of appropriate treatment.
2. Quality of care as measured by adherence to recommended
iCCM practice or guidelines.
3. Measures of mortality (neonatal, infant, under-five
mortality and any mortality (neonatal + under-five mortality)).
4. Case load or severity of illness at health facilities.
5. Coverage of care-seeking to an ’appropriate provider’ of
treatment services.
We will use the considerations recommended in the EPOC
GRADE worksheets (design, risk of bias, inconsistency, indi-
rectness, imprecision, and other) to assess the certainty of evi-
dence across studies as it relates to the main outcomes (EPOC
2017g). We will use methods and recommendations described in
Section 8.5 and Chapter 12 of the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011) and the EPOC
GRADE worksheets (EPOC 2017g), and using GRADEpro soft-
ware (GRADEpro GDT 2015). We will express the results as one
of four levels of quality (high, moderate, low or very low). We will
justify all decisions to down- or up-grade the quality of studies us-
ing footnotes andmake comments to aid readers’ understanding of
the review where necessary. We will consider whether there is any
additional outcome information that could not be incorporated
into meta-analyses and note this in the comments and state if it
supports or contradicts the information from the meta-analyses.
If it is not possible to meta-analyse the data we will summarise the
results in the text using a structured synthesis (EPOC2017f). This
structured synthesis may include reporting on interquartile ranges
and ranges of effects for relevant outcomes and we will include a
summary of the findings in the review text. Guided by the frame-
work presented in Table 1 and text in the sections ’Description of
the intervention’ and ’How the intervention might work’ (above),
this structured analysis may also include a description of the in-
tervention mechanisms described across the studies. We will in-
clude information from the structured synthesis in the ’Summary
of findings’ table.
Subgroup analysis and investigation of heterogeneity
We will consider sub-analyses for a number of groups as we as-
sume that the effects of iCCM on our outcomes of interest may
vary according to context (Bennett 2015; Bosch-Capblanch 2014;
Haines 2007; Kok 2014).
We plan to carry out the following subgroup analyses.
1. Country baseline income level (low income, middle
income) as defined by the Human Development Index. We
hypothesize that effects may be greater for low-income countries
because the gap in access to care is greater in the former;
additionally the effects may be greater in low-income countries
because the share of under-five mortality (i.e. the target group for
iCCM) is greater in low-income countries compared to middle-
income countries, where neonatal mortality makes up a greater
share of under-five mortality (Liu 2015; You 2015).
2. Household wealth as defined as household assets or income:
poorer households may have less access to, and choice of,
providers and therefore may benefit more from iCCM
(Geldsetzer 2014).
3. Gender of child (male/female): we hypothesize that in some
contexts social norms may influence preferential care-seeking
behaviour for male children (Geldsetzer 2014; Treleaven 2016).
4. Ratio of iCCM providers per population (higher ratio/
lower ratio): although the evidence is unclear on whether the
ratio of iCCM providers affects outcomes (Oliphant 2014;
Amouzou 2016), we hypothesize that higher ratios of iCCM
providers per population may have greater effects due to greater
exposure to iCCM providers.
5. Active case-finding compared to passive case-finding:
although the evidence is unclear on whether the choice of case-
finding approach (active or passive) affects outcomes (Oliphant
2014), we hypothesize that iCCM providers that do passive case-
finding (i.e. work from a fixed site and wait for care-seekers) may
have a greater effect than iCCM providers conducting active
case-finding because mothers may know better where to find the
iCCM providers and - in large populations - iCCM providers
may not be able to reach all children in need through active case-
finding.
The following outcomes will be used in subgroup analysis.
1. Coverage of appropriate treatment.
2. Quality of care as measured by adherence to recommended
iCCM practice or guidelines.
3. Measures of mortality (neonatal, infant, under-five
mortality and any mortality (neonatal + under-five mortality)).
4. Case load or severity of illness at health facilities.
5. Coverage of care-seeking to an ’appropriate provider’ of
treatment services.
Subgroup analyses will check for variation in the intervention ef-
fect across different populations, interventions or setting charac-
teristics. We will use meta-regression analysis to test for subgroup
interactions. Using the Stata v14 command “metan” we will in-
vestigate differences between two or more subgroups (Borenstein
2008; StataCorp 2015). We will be using the standard Bonferroni
correction where the usual 0.050 criterion for statistical signifi-
cance will be divided by 25 (5 subgroups * 5 outcomes) to yield
the Bonferroni critical value of 0.002 (0.05/25), so a comparison
would need to have P less than 0.002 to be significant. Alterna-
tively, we will control for multiple testing by adjusting the false
discovery rate using the more powerful Benjamini-Hochberg pro-
cedure (Benjamini 1995).
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Sensitivity analysis
We are aware that overall risk estimates from any meta-analysis
can be susceptible to outlying effect sizes, impacting on a change
in statistical significance and clinical relevance and even a reversal
of effectiveness of an intervention. Therefore, we will perform
sensitivity analysis defined a priori to assess the robustness of our
findings. We will conduct the following sensitivity analyses.
1. Restricting the analysis to published studies.
2. Restricting the analysis for each outcome to studies with a
low risk of bias for the particular outcome. For the prespecified
outcomes in this review, the most important risk of bias domains
are: a) baseline outcomes and characteristics; and b)
completeness of outcome data.
3. Restricting analysis to studies with four or more illnesses;
(although we will stratify analysis as two or more illnesses and
three or more illnesses, the right number may be four or more
illnesses, or this may not matter at all).
We will perform additional meta-analyses and generate forest plots
by omitting studies that were unpublished (for 1) or with extreme
risk of bias (for 2) or sparse levels of illnesses (for 3) to assess
their impact on results of the main meta-analysis. We will also
do a number of additional meta-analyses where a priori identified
studies will be omitted one at a time (and using the remaining N
− 1 studies) where N is the number of included studies in the
main meta-analysis.
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A D D I T I O N A L T A B L E S
Table 1. iCCM components categorized by the EPOC taxonomy of health systems interventions
EPOC Category EPOC Sub-category Target Intervention iCCM Component and
Purpose
Who provides care
and how the healthcare
workforce is managed
Role expansion or task
shifting
Recruitment and reten-
tion strategies for under-
served areas
Health workers Interventions to recruit,
train and
retain lay health workers
to provide iCCM
Training and deploy-
ment component: inter-
ventions with the main
purpose of increasing ac-
cess to integrated case
management services for
children younger than
five years of age by
increasing the number
of lay health workers
trained on the generic or
adapted WHO/
UNICEF guidelines for
integrated case manage-
ment services and de-
ployed where facility-
based case management
services are limited
Interventions targeted at
health workers
Clinical practice guide-
lines
Health workers Implementation of sim-
pli-
fied IMCI-adapted clin-
ical guidelines for iCCM
providers
Mechanisms for the pay-
ment of health services
Payment methods for
health workers
Health workers Inter-
ventions for the payment
of iCCM providers such
as salary, fees for service,
capitation
Coordinationof care and
management of care pro-
cesses
Referral systems Health system Interventions to improve
systems for referral of pa-
tients between commu-
nity and facility levels
Systems component: in-
terventions with the
main purpose of improv-
ing implementation of
iCCM by strengthening
health systems organiza-
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Table 1. iCCM components categorized by the EPOC taxonomy of health systems interventions (Continued)
tion and management,
including supplies, spefi-
cially related to iCCM
Procurement and dis-
tribution of supplies:
systems for procuring
and distributing drugs or
other supplies
Interventions to improve
the supply of iCCM
drugs and equipment
Information and com-
munication technology
(ICT)
Health information sys-
tems
Health system Interventions to improve
health information sys-
tems and use of infor-
mation communication
technology for iCCM
The use of informa-
tion and communica-
tion technology
Interventions targeted at
health workers
Monitoring the perfor-
mance of the delivery of
healthcare
Health workers, super-
visors, managers, policy
makers
Interventions to improve
monitoring, evaluation,
and research for iCCM
Managerial supervision Supervisors, managers Interventions to improve
managerial supervision
of iCCM providers
Authority and account-
ability for health policies
Community
mobilization
Communities and care-
givers
Interventions to pro-
mote good practices for
health and nutrition and
generate demand for use
of iCCMproviderswhen
children are ill
Communication
and community mobi-
lization component: in-
terven-
tions with the main pur-
pose of promoting good
practices for health and
nutrition and generating
demand for case man-
agement services for ill
children through com-
munication and mobi-
lization of communities
and caregivers
Based on EPOC 2015
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Table 2. Approach for summary assessments of the risk of bias for each outcome (across domains) within and across studies
Risk of bias Interpretation Within a study Across studies
Low risk of bias Plausible bias unlikely to seriously
alter the results.
Low risk of bias for all key domains. Most information is from studies at
low risk of bias.
Unclear risk of bias Plausible bias that raises some
doubt about the results.
Unclear risk of bias for one or more
key domains.
Most information is from studies at
low or unclear risk of bias
High risk of bias Plausible bias that seriously weak-
ens confidence in the results
High risk of bias for one or more
key domains.
The proportion of information
from studies at high risk of bias is
sufficient to affect the interpreta-
tion of results
From Higgins 2011
A P P E N D I C E S
Appendix 1. MEDLINE Search Strategy
MEDLINE Epub Ahead of Print, In-Process & Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to Present,
Ovid
# Searches Results
1 integrated community case management of childhood illness*.
ti,ab,kf
34
2 Community Health Workers/ 4523
3 Allied Health Personnel/ 11304
4 Volunteers/ 9086
5 exp Peer Group/ 18630
6 Home Nursing/ 8784
7 Midwifery/ 18126
8 Delivery of health Care, Integrated/ 10982
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(Continued)
9 integrated management.ti,ab,kf. 1351
10 iccm.ti,ab,kf. 162
11 (community worker? or community health* worker? or com-
munity health care worker?).ti,ab,kf
4030
12 (community level worker? or community level health* worker?
or community level health care worker?).ti,ab,kf
33
13 (community health* provider? or community health care
provider? or community health* aide? or community health
care aide? or community health* agent? or community health
care agent? or community health* assistant? or community
health care assistant? or community health* promoter? or com-
munity health care promoter? or community health* distrib-
utor? or community health care distributor? or community
health* surveyor? or community health care surveyor?).ti,ab,kf
513
14 (community based health* provider? or community based
health care provider? or community based health* aide? or com-
munity based health care aide? or community based health*
agent? or community based health care agent? or community
based health* assistant? or community based health care assis-
tant? or community based health* promoter? or community
based health care promoter? or community based health* dis-
tributor? or community based health care distributor? or com-
munity based health* surveyor? or community based health
care surveyor?).ti,ab,kf
52
15 (community volunteer? or community health* volunteer? or
community health care volunteer?).ti,ab,kf
884
16 (community health* educator? or community health care edu-
cator?).ti,ab,kf
60
17 health promoter?.ti,ab,kf. 511
18 (allied health personnel or allied health* worker? or allied health
care worker?).ti,ab,kf
363
19 (health assistant? or welfare assistant?).ti,ab,kf. 223
20 (voluntary worker? or voluntary health* worker? or voluntary
health care worker? or volunteer worker? or volunteer health*
worker? or volunteer health care worker?).ti,ab,kf
410
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(Continued)
21 (voluntary team? or voluntary health* team? or voluntary health
care team? or volunteer team? or volunteer health* team? or
volunteer health care team? or voluneer collaborator?).ti,ab,kf
29
22 (health* auxiliary or health* auxilliary or health care auxiliary or
health care auxilliary or health* auxiliaries or health* auxilliaries
or health care auxiliaries or health care auxilliaries or auxiliary
nurse? or auxilliary nurse?).ti,ab,kf
390
23 (village health* worker? or village health care worker? or village
health* volunteer? or village health care volunteer?).ti,ab,kf
433
24 (lay worker? or lay health* worker? or lay health care worker?).
ti,ab,kf
391
25 (lay personnel or lay health* personnel or lay health care per-
sonnel).ti,ab,kf
57
26 (lay advisor? or lay health* advisor? or lay health care advisor?
or lay counselor? or lay health* counselor? or lay health care
counselor? or lay counsellor? or lay health* counsellor? or lay
health care counsellor? or adherence counselor? or adherence
counsellor?).ti,ab,kf
385
27 (lay volunteer? or lay health* volunteer? or lay health care vol-
unteer?).ti,ab,kf
121
28 (peer educator? or peer counselor? or peer counsellor?).ti,ab,kf 915
29 lady health*.ti,ab,kf. 140
30 (child health* worker? or child health care worker? or maternal
health* worker? or maternal health care worker?).ti,ab,kf
65
31 (traditionalmidwife or traditionalmidwives or traditional birth
attendant? or doula? or skilled birth attendant?).ti,ab,kf
2152
32 (health* extension worker? or health care extension worker?).
ti,ab,kf
192
33 (paramedics or paramedical personnel).ti,ab,kf. 4312
34 (drug seller? or drug distributor? or drug vendor?).ti,ab,kf 261
35 (medicin* seller? or medicin* distributor? or medicin* vendor?
).ti,ab,kf
99
36 licensed chemical seller?.ti,ab,kf. 8
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(Continued)
37 (pharmaceutical seller? or pharmaceutical distributor? or phar-
maceutical vendor?).ti,ab,kf
14
38 (community management or community based management
or community case management or community based case
management).ti,ab,kf
782
39 (home based management or home nursing or home based
nursing or home based carer?).ti,ab,kf
1578
40 (barefoot doctor? or traditional healer? or link worker? or front
line worker? or front line health* worker? or front line health
care worker? or family planning personnel or family planning
worker?).ti,ab,kf
3374
41 (health surveillance assistant? or relais or accredited social health
activist? or anganwadi worker? or agentes polivalentes ele-
mentares or shasthya shebika or promotoras or keshatan or gizi
or health development army or therapy supporter or behvarz
or brigadista?).ti,ab,kf
500
42 or/2-41 [Community Health Workers] 96307
43 Disease Management/ 30902
44 exp Malaria/ 64206
45 exp Diarrhea/ 51460
46 exp Malnutrition/ 118905
47 exp Infant, Newborn, Diseases/ 171305
48 exp Sepsis/ 115868
49 exp Respiratory Tract Infections/ 346880
50 Dehydration/ 12703
51 exp Fever/ 41978
52 disease management.ti,ab,kf. 12832
53 (malaria or paludism or diarrhea or diarrhoea or diarrheal dis-
ease? or diarrhoeal disease? or pneumonia or malnutrition or
mal nutrition or malnurished or mal nurished or respiratory
infection? or respiratory tract infection? or sepsis or severe in-
590676
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(Continued)
fection? or fever or dehydration or dehydrated or danger sign?
).ti,ab,kf
54 ((newborn? or new born? or neonat* or neo nat* or perinatal
or peri natal or childhood) adj3 (disease? or illness*)).ti,ab,kf
30525
55 or/43-54 [Conditions to be managed] 1276234
56 Developing Countries.sh,kf. 84665
57 (Africa or Asia or Caribbean or West Indies or South America
or Latin America or Central America).hw,kf,ti,ab,cp
246675
58 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brasil or Brazil or Bulgaria or
Burkina Faso or Burkina Fasso or Upper Volta or Burundi or
Urundi or Cambodia or Khmer Republic or Kampuchea or
Cameroon or Cameroons or Cameron or Camerons or Cape
Verde or Central African Republic or Chad or Chile or China
or Colombia or Comoros or Comoro Islands or Comores or
Mayotte or Congo or Zaire or Costa Rica or Cote d’Ivoire or
Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia
or Czech Republic or Slovakia or Slovak Republic or Djibouti
or French Somaliland or Dominica or Dominican Republic or
East Timor or East Timur or Timor Leste or Ecuador or Egypt
or United Arab Republic or El Salvador or Eritrea or Estonia or
Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or
Gaza or Georgia Republic or Georgian Republic or Ghana or
Gold Coast or Greece or Grenada or Guatemala or Guinea or
Guam or Guiana or Guyana or Haiti or Honduras or Hungary
or India or Maldives or Indonesia or Iran or Iraq or Isle of Man
or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiri-
bati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz
Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia
or Lebanon or Lesotho or Basutoland or Liberia or Libya or
Lithuania or Macedonia or Madagascar or Malagasy Republic
orMalaysia orMalaya orMalay or Sabah or Sarawak orMalawi
or Nyasaland or Mali or Malta or Marshall Islands or Mauri-
tania or Mauritius or Agalega Islands or Mexico or Microne-
sia or Middle East or Moldova or Moldovia or Moldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
Netherlands Antilles or New Caledonia or Nicaragua or Niger
or Nigeria or NorthernMariana Islands or Oman or Muscat or
3335437
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(Continued)
Pakistan or Palau or Palestine or Panama or Paraguay or Peru
or Philippines or Philipines or Phillipines or Phillippines or
Poland or Portugal or Puerto Rico or Romania or Rumania or
Roumania or Russia or Russian or Rwanda or Ruanda or Saint
Kitts or St Kitts or Nevis or Saint Lucia or St Lucia or Saint
Vincent or St Vincent or Grenadines or Samoa or Samoan Is-
lands or Navigator Island or Navigator Islands or Sao Tome or
Saudi Arabia or Senegal or Serbia or Montenegro or Seychelles
or Sierra Leone or Slovenia or Sri Lanka or Ceylon or Solomon
Islands or Somalia or South Africa or Sudan or Suriname or
Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan
or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or
Togolese Republic or Tonga or Trinidad or Tobago or Tunisia
or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine
or Uruguay or USSR or Soviet Union or Union of Soviet So-
cialist Republics or Uzbekistan or Uzbek or Vanuatu or New
Hebrides or Venezuela or Vietnam or Viet Nam or West Bank
or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia)
.hw,kf,ti,ab,cp
59 ((developing or less* developed or under developed or under-
developed or middle income or low* income or underserved or
under served or deprived or poor*) adj (countr* or nation? or
population? or world)).ti,ab,kf
114585
60 ((developing or less* developed or under developed or under-
developed or middle income or low* income) adj (economy or
economies)).ti,ab,kf
447
61 (low* adj (gdp or gnp or gross domestic or gross national)).ti,
ab,kf
217
62 (low adj3 middle adj3 countr*).ti,ab,kf. 10450
63 (lmic or lmics or third world or lami countr*).ti,ab,kf. 5637
64 transitional countr*.ti,ab,kf. 153
65 or/56-64 [LMICs] 3476023
66 randomized controlled trial.pt. 496470
67 controlled clinical trial.pt. 99235
68 multicenter study.pt. 248570
69 pragmatic clinical trial.pt. 731
70 non-randomized controlled trials as topic/ 247
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(Continued)
71 interrupted time series analysis/ 360
72 controlled before-after studies/ 297
73 (randomis* or randomiz* or randomly).ti,ab. 804311
74 groups.ab. 1844027
75 (trial or multicenter or multi center or multicentre or multi
centre).ti
229718
76 (intervention? or effect? or impact? or controlled or control
group? or (before adj5 after) or (pre adj5 post) or ((pretest or pre
test) and (posttest or post test)) or quasiexperiment* or quasi
experiment* or pseudo experiment* or pseudoexperiment* or
evaluat* or time series or time point? or repeated measur*).ti,
ab
8684216
77 or/66-76 9701626
78 exp Animals/ 22477984
79 Humans/ 17802402
80 78 not (78 and 79) 4675582
81 review.pt. 2440369
82 meta analysis.pt. 91502
83 news.pt. 188730
84 comment.pt. 723964
85 editorial.pt. 461089
86 cochrane database of systematic reviews.jn. 14513
87 comment on.cm. 723962
88 (systematic review or literature review).ti. 108531
89 or/80-88 8177064
90 77 not 89 [Methods filter] 6777056
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(Continued)
91 1 or (42 and 55 and 65 and 90) [Community health workers
ANDConditions to be managed ANDLMICs ANDMethods
filter]
1982
92 remove duplicates from 91 1780
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